언어선택 ENG
전체메뉴

Business Strategy

Innovative Medicines based on
ImmunoModulatory Biologics

Our proprietary platform technology supports the expansion of new drug pipelines while an open innovation strategy allows us to promptly advance into the clinic. With our lead pipeline, we are fast-tracking to become a clinical-stage biotech company.

사업전략

Two track strategy
of R&D and Commercialization

플랫폼기술 기반 수익모델, 파이프라인 기술수출(L/O)

좌우로 스크롤 하시면 전체 내용을 확인할 수 있습니다.